Clinical definition for secondary resistance to immunotherapy–targeted therapy combinations
| Resistance phenotype | Drug exposure requirement | Best response |
| Secondary resistance | >6 months | CR, PR SD ≥6 months |
CR, complete response; PR, partial response; SD, stable disease.